There are moments in cardiac care which happen more often than they should.
A patient presents with palpitations, unexplained syncope, or intermittent symptoms which point toward an arrhythmia. The physician prescribes an Extended Holter monitor. The device is applied, the patient is sent home, and then — nothing. No data. No updates. No visibility.
For days or weeks, that patient may walk around experiencing symptoms, wondering what is happening, while their cardiac data sits locked inside a device the physician cannot access.
At Rhythm Express, we call these ghost patients. And, in the era of near real-time data transmission, they should not exist.
The hidden cost of traditional extended Holter monitoring
Extended Holter monitoring was designed to capture cardiac events which shorter duration recordings miss. For patients with intermittent arrhythmias, a 7-day or 14-day monitor can be the difference between a diagnosis and continued uncertainty. The clinical rationale is sound.
The workflow, however, has not kept pace with what modern technology makes possible.
With most traditional Extended Holter systems, data does not leave the device until the study is complete. That means before a physician can review a single data point, an entire sequence of steps must occur:
The study must run to completion. The monitor must be removed by the patient and packaged for return. The device must be shipped back to a clinic or independent diagnostic testing facility (IDTF). Shipping delays — or lost packages — introduce additional uncertainty. Once received, the device must be cleaned and processed. Data must be extracted from the hardware. Technicians must analyze the full recording. A report must be generated and uploaded to the ordering system. Only then can the physician review results and begin forming a diagnosis.
From monitor removal to actionable report, this process routinely takes one-to-two weeks. When shipping complications, patient compliance or processing backlogs arise, it can stretch further.
For a 7-day study, a physician may wait three weeks or more to learn what happened during those seven days.
When the device fails mid-study
The delay problem compounds significantly when equipment issues arise during the monitoring period.
Adhesive failures are among common complications in Extended Holter studies. If a fixed-lead detaches and the patient cannot resecure it, the recording may be compromised — or lost entirely. With some traditional systems, this means the patient must obtain a replacement device and restart the study from the beginning.
That is not a minor inconvenience. It means additional weeks of waiting for a patient who may already be anxious about their symptoms. It means a gap in care during which a clinically significant event could go undetected. And it means the physician remains in the dark while the diagnostic clock resets.
How can a fragile workflow like this be justified when better options exist.
Why the delay matters clinically
A three-week gap between monitoring and diagnosis is not merely a workflow inefficiency. For some patients, it could carry real clinical risk.
Consider the experience from the patient’s perspective. They are wearing a remote cardiac monitor because their physician suspects something may be wrong with their heart. They are symptomatic. They have questions. And the answer — which exists, captured on the device on their chest — is completely inaccessible to the physician treating them. That is the ghost patient problem.
What near real-time monitoring changes
The Rhythm Express RX-1 mini transmits Extended Holter and MCT data in near real-time, making reports available within 24 to 48 hours of data capture — while the study is still in progress.
That single change in workflow architecture eliminates most of the problems described above.
Physicians gain visibility into patient data during the active monitoring period, not weeks after it ends. If a clinically significant event occurs on day two of a seven-day study, the physician does not have to wait until day twenty to know about it. If an adhesive issue arises, it can be identified and addressed while the study still has time to capture meaningful data.
The diagnostic timeline compresses from weeks to days. The patient experience transforms from anxious silence to responsive care. And the physician has the information needed to act — while acting still makes a difference.
The workflow physicians deserve
Extended Holter monitoring is a valuable clinical tool. The question is not whether to use it — it is whether the workflow surrounding it serves patients well or simply reflects the limitations of older technology.
A monitoring system which transmits data in near real-time does not change what the physician is looking for. It changes when the physician can see it. And in cardiac care, timing is rarely irrelevant.
The steps defining traditional extended Holter workflow — shipping, processing, extraction, batch analysis — are not clinical requirements. They are artifacts of hardware-dependent systems predating modern transmission capabilities. There is no patient benefit to waiting for a physical device to be mailed back before analysis can begin.
Near real-time transmission is not a premium feature. It is the baseline standard modern cardiac monitoring should meet.
Don’t let your patients become ghost patients
Every day a physician operates without visibility into an active monitoring study is a day a patient’s data exists without clinical oversight. For most patients, the gap will pass without consequence. For some, it will not.
The ghost patient problem is solvable. The technology to eliminate it exists today.
The Question: Is the selected monitoring system built to use it?
The Rhythm Express RX-1 mini delivers near real-time Extended Holter and MCT data transmission, with reports available within 24–48 hours of capture. To see how it fits your clinical workflow, request a demo.